首页
产品目录
分子砌块
按官能团
酰胺类
16-酸甲酯(5S,8S,11S,14S)-11-[(1H-咪唑-5-基)甲基]-14-(2-氟乙酰基)-5-(2-甲基丙基)-8-(3-甲氧基-3-氧代丙基)-1-苯基-2-氧杂-4,7,10,13-四氮杂十六烷-3,6,9,12-四酮酸酯
16-酸甲酯(5S,8S,11S,14S)-11-[(1H-咪唑-5-基)甲基]-14-(2-氟乙酰基)-5-(2-甲基丙基)-8-(3-甲氧基-3-氧代丙基)-1-苯基-2-氧杂-4,7,10,13-四氮杂十六烷-3,6,9,12-四酮酸酯
Methyl (5S,8S,11S,14S)-11-((1H-imidazol-5-yl)methyl)-14-(2-fluoroacetyl)-5-isobutyl-8-(3-methoxy-3-oxopropyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13-tetraazahexadecan-16-oate
产品编号 :
ACOJCY685
Cas No. :
210345-04-3
包装规格
纯度
目录价
会员专享价
库存
数量
1mg
98%
¥2403
询价
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
210345-04-3
中文名称
16-酸甲酯(5S,8S,11S,14S)-11-[(1H-咪唑-5-基)甲基]-14-(2-氟乙酰基)-5-(2-甲基丙基)-8-(3-甲氧基-3-氧代丙基)-1-苯基-2-氧杂-4,7,10,13-四氮杂十六烷-3,6,9,12-四酮酸酯
英文名称
Methyl (5S,8S,11S,14S)-11-((1H-imidazol-5-yl)methyl)-14-(2-fluoroacetyl)-5-isobutyl-8-(3-methoxy-3-oxopropyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13-tetraazahexadecan-16-oate
别名
BENZYLOXYCARBONYL-LEU-GLU(OME)-HIS-ASP(OME)-FLUOROMETHYLKETONE;CASPASE-9 INHIBITOR;CASPASE-9 INHIBITOR (FLUOROMETHYLKETONE);CASPASE-9 INHIBITOR I;Z-LEHD-FLUOROMETHYLKETONE;Z-LEHD-FMK;Z-LE(OME)HD(OME)-FLUOROMETHYLKETONE;Z-LE(OME)HD(OME)-FMK
标准英文名
methyl (5S,8S,11S,14S)-11-((1H-imidazol-5-yl)methyl)-14-(2-fluoroacetyl)-5-isobutyl-8-(3-methoxy-3-oxopropyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13-tetraazahexadecan-16-oate
MDL No.
MFCD01862609
分子式
C3 2 H4 3 FN6 O1 0
分子量
690.73
精确分子量
690.30
SMILES
COC(=O)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)OC)C(=O)CF
标准SMILES
CC(C)C[C@H](NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)OC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)OC)C(=O)CF
用途
Z-LEHD-FMK is a selective and irreversible caspase-9 inhibitor that prevents lethal reperfusion injury and attenuates apoptosis; it exhibits neuroprotective effects in a rat spinal cord injury model; it protects HCT116 and 293 cells from TRAIL-induced toxicity; it protects normal human hepatocytes from TRAIL-induced apoptosis; it prevents procaspase-3 cleavage in HCT116 cells; and it reduces apoptotic cell counts in spinal cord injury rats when administered intravenously.
InChIKey
YXRKBEPGVHOXSV-QORCZRPOSA-N